A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19
Clinical trial NCT05890612 · RECRUITING
Trial details
- NCT number
- NCT05890612
- Sponsor
- Pfizer
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-29
- Primary completion
- 2029-02-17
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.